Study of the Progression of Chronic Cardiovascular Conditions
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Prolaio
- Study ID
- NCT07420907
- Status
- Recruiting
Conditions
- Aortic Stenosis
- Aortic Stenosis Disease
- Cardiovascular Disease (CVD)
- Dilated Cardiomyopathy
- Dilated Cardiomyopathy (DCM)
- Dilated Cardiomyopathy, Familial
- Heart Failure
- Hypertension
- Hypertension (HTN)
- Hypertrophic Cardiomyopathy Patients
- Hypertrophic Cardiomyopathy Without Obstruction
- Hypertrophic Cardiomyopathy, Obstructive
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.
Key Dates
- Start date
- Oct 30, 2025
- Status verified
- Feb 2026
- Primary completion
- Oct 31, 2030
- Completion
- Oct 31, 2030
Study Design
- Enrollment
- 5,000 participants (estimated)
Arms
- Arm: Cardiovascular Disease (CVD)Participants who have been diagnosed including but not limited to the following Cardiovascular Disease types: Aortic Stenosis, Heart Failure, Hypertension Obstructive Cardiomyopathy, Dilated Cardiomyopathy
Primary Outcome Measure
Longitudinal Assessment of Clinical Status [ Time Frame: Baseline through each 90-day cycle ]
Central Contacts
- Study Team OCORO Study1-855-869-9054
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Prolaio | Chicago | Illinois | 60606 | - |
Find similar trials in Chicago, IL
By condition
By specialty
By research site
Related Studies
- PARTNER 3 Trial - Aortic Valve-in-ValveRecruiting · Edwards Lifesciences · Phoenix, Arizona
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona